Group B Strep Prevention - FOI Response Register

1. Please supply a copy of your guideline(s) relating to group B Strep during pregnancy, labour, and in new-born babies.

See attached:

Group B Streptococcus in Pregnancy

Group B Streptococcus Guidlines

2. Please provide the date when your guidelines relating to group B Strep during pregnancy, labour, and in newborn babies were last updated.

Policy updated May 24 and is currently being reviewed by the appropriate Governance bodies before final sign off

3. Please provide the date when your guidelines relating to group B Strep during pregnancy, labour, and in newborn babies are due to be updated

See answer to Q2

4. Do you provide information materials about group B Strep to all pregnant women and people as a routine part of antenatal care? (Yes/No)

No

5. If you do not provide information materials about group B Strep to all pregnant women and people, do you provide them to any of the following groups during antenatal care? (Select all that apply) those who have previously had a baby who developed GBS infection those where GBS was detected before the current pregnancy (swab or urine) those where GBS was detected during the current pregnancy (swab or urine) those who are in preterm labour those with preterm rupture of membranes those with prolonged rupture of membranes those who request information

Those who have previously had a baby who developed GBS infection

Those where GBS was detected during the current pregnancy (swab or urine)

6. Please supply copies of the information materials (physical and/or digital) which are given to pregnant women and people about GBS as a routine part of antenatal care.

     RCOG GBS in pregnancy and new born babies

7. Do you offer testing specifically for maternal GBS carriage to any pregnant women or people in either late pregnancy or in labour? [By this we mean a test specifically intended to detect GBS carriage, rather than a general test for the presence of any microorganisms of interest] (Yes/No)

No

8. If you offer testing specifically for maternal GBS carriage in late pregnancy or in labour, do you offer: (Select all that apply) Testing late in pregnancy Testing in labour

N/A

9. Do you offer GBS-specific testing for maternal GBS carriage to: (Select all that apply) All pregnant women and people Those who previously had a baby who developed GBS infection Those where GBS was detected in a previous pregnancy Those who request it Those in other circumstances (for example, for reasons such as PPROM or vaginal discharge) Other (please state)

Testing is only undertaken when the woman presents with symptoms and a urine sample or swab is indicated

10. If you undertake GBS-specific testing for maternal GBS carriage, which of the following specimen types do you collect (Select all that apply):

• Vaginal Swab alone
• Rectal Swab alone
• Both Vaginal and Rectal Swab(s)
• Other (please state)

N/A

11. If you undertake GBS-specific testing for maternal GBS carriage, which detection method is used by the Microbiology laboratory? (Select all that apply) Direct culture on non-selective, non-chromogenic media Direct culture on selective &/or indicator media Broth enrichment with subculture onto non-selective, non-chromogenic media Broth enrichment with subculture onto selective &/or chromogenic media PCR (for example, Cepheid GeneXpert) Other (Please state)

Yes, Direct culture on selective &/or indicator media

12. Does your lab offer any of the following (Select all that apply):

Enriched Culture Medium (ECM) as part of the routine lab test repertoire ECM offered, with samples referred to another lab PCR as part of the routine lab test repertoire PCR offered, with samples referred to another lab Other (please state)

No

13. Do you provide training on group B Strep in labour to (Select all that apply) Midwifery staff Obstetric staff Neonatal staff Laboratory staff Others (please state)

Midwifery Staff

14. Do you use the Kaiser Permanente Neonatal Early-Onset Sepsis Calculator? (Yes/No)

No

15. If yes to Q14, is there a prospective audit in place? (Yes/No) 14b. If yes to Q14, from what gestation do you use the calculator? Please specify weeks and days e.g. 34+0

N/A

16. Do you use digital platforms to analyse your Trust/Board’s rates of GBS infection [invasive neonatal or maternal infections - not non-invasive infections, or infections that are not neonatal/pregnancy-related] (Yes/No)

No

17. If you use digital platforms to analyse your Trust/Board’s rates of GBS infection as defined in Q15, do you use this for: (Select all that apply) Early-onset GBS infection Late-onset GBS infection Maternal GBS infection Others (please state)

N/A